Recent Advances in the Transition-Metal-Free Synthesis of Quinazolines

被引:12
作者
Tamatam, Rekha [1 ,2 ]
Shin, Dongyun [1 ,2 ]
机构
[1] Gachon Univ, Coll Pharm, 191 Hambakmoe Ro, Incheon 21936, South Korea
[2] Gachon Univ, Gachon Pharmaceut Res Inst, 191 Hambakmoe Ro, Incheon 21936, South Korea
来源
MOLECULES | 2023年 / 28卷 / 07期
基金
新加坡国家研究基金会;
关键词
quinazolines; transition-metal-free; synthesis; advantages; limitations; mechanism; ONE-POT SYNTHESIS; CELL LUNG-CANCER; 2-SUBSTITUTED QUINAZOLINES; SUBSTITUTED QUINAZOLINES; OXIDATIVE ANNULATION; EFFICIENT SYNTHESIS; CATALYZED SYNTHESIS; KINASE INHIBITOR; MOLECULAR-IODINE; H BONDS;
D O I
10.3390/molecules28073227
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinazolines are a privileged class of nitrogen-containing heterocycles, widely present in a variety of natural products and synthetic chemicals with a broad spectrum of biological and medicinal activities. Owing to their pharmaceutical applications and promising biological value, a variety of synthetic methodologies have been reported for these scaffolds. From the perspective of green and sustainable chemistry, transition-metal-free synthesis provides an alternative method for accessing several biologically active heterocycles. In this review, we summarize the recent progress achieved in the transition-metal-free synthesis of quinazolines and we cover the literature from 2015 to 2022. This aspect is present alongside the advantages, limitations, mechanistic rationalization, and future perspectives associated with the synthetic methodologies.
引用
收藏
页数:29
相关论文
共 88 条
[11]   CATALYSTS FOR SILYLATIONS WITH 1,1,1,3,3,3-HEXAMETHYLDISILAZANE [J].
BRUYNES, CA ;
JURRIENS, TK .
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (20) :3966-3969
[12]   Dual kinase inhibition in the treatment of breast cancer: Initial experience with the EGFR/ErbB-2 inhibitor lapatinib [J].
Burris, HA .
ONCOLOGIST, 2004, 9 :10-15
[13]   TMSOTf-catalyzed synthesis of substituted quinazolines using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions [J].
Chan, Chieh-Kai ;
Lai, Chien-Yu ;
Wang, Cheng-Chung .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2020, 18 (36) :7201-7212
[14]   Base-Promoted Synthesis of 2-Aryl Quinazolines from 2-Aminobenzylamines in Water [J].
Chatterjee, Tanmay ;
Kim, Dong In ;
Cho, Eun Jin .
JOURNAL OF ORGANIC CHEMISTRY, 2018, 83 (14) :7423-7430
[15]   Recent trends in the development of sustainable catalytic systems for the oxidative cleavage of cycloalkenes by hydrogen peroxide [J].
Cousin, Tony ;
Chatel, Gregory ;
Kardos, Nathalie ;
Andrioletti, Bruno ;
Draye, Micheline .
CATALYSIS SCIENCE & TECHNOLOGY, 2019, 9 (19) :5256-5278
[16]   Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors [J].
Cruz-Lopez, O. ;
Conejo-Garcia, A. ;
Nunez, M. C. ;
Kimatrai, M. ;
Garcia-Rubino, M. E. ;
Morales, F. ;
Gomez-Perez, V. ;
Campos, J. M. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) :943-963
[17]   Molecular Iodine Catalysed Benzylic sp3 C-H Bond Amination for the Synthesis of 2-Arylquinazolines from 2-Aminobenzaldehydes, 2-Aminobenzophenones and 2-Aminobenzyl Alcohols [J].
Deshmukh, Dewal S. ;
Bhanage, Bhalchandra M. .
SYNLETT, 2018, 29 (07) :979-+
[18]   Chemical Insights Into the Synthetic Chemistry of Quinazolines: Recent Advances [J].
Faisal, Muhammad ;
Saeed, Aamer .
FRONTIERS IN CHEMISTRY, 2021, 8
[19]   No photocatalyst required - versatile, visible light mediated transformations with polyhalomethanes [J].
Franz, Johannes F. ;
Kraus, Wolfgang B. ;
Zeitler, Kirsten .
CHEMICAL COMMUNICATIONS, 2015, 51 (39) :8280-8283
[20]   A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group [J].
Goss, Glenwood ;
Shepherd, Frances A. ;
Laurie, Scott ;
Gauthier, Isabelle ;
Leighl, N. ;
Chen, Eric ;
Feld, Ronald ;
Powers, Jean ;
Seymour, Lesley .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) :782-788